Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus +/- Paclitaxel in Cisplatin-Ineligible Advanced Urothelial Carcinoma
NCT01215136Phase 2Terminated
- Start
- Dec 2010
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in urothelial carcinoma (UC). Started Dec 2010; status: terminated.
02
Drugs
everolimus
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT01215136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01215136.